369 related articles for article (PubMed ID: 16733262)
1. Tumor-associated antigen arrays for the serological diagnosis of cancer.
Casiano CA; Mediavilla-Varela M; Tan EM
Mol Cell Proteomics; 2006 Oct; 5(10):1745-59. PubMed ID: 16733262
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
Zhang JY; Casiano CA; Peng XX; Koziol JA; Chan EK; Tan EM
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
Liu W; Peng B; Lu Y; Xu W; Qian W; Zhang JY
Autoimmun Rev; 2011 Apr; 10(6):331-5. PubMed ID: 21167321
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to tumor-associated antigens: reporters from the immune system.
Tan EM; Zhang J
Immunol Rev; 2008 Apr; 222():328-40. PubMed ID: 18364012
[TBL] [Abstract][Full Text] [Related]
5. Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.
Zhu Q; Liu M; Dai L; Ying X; Ye H; Zhou Y; Han S; Zhang JY
Autoimmun Rev; 2013 Oct; 12(12):1123-8. PubMed ID: 23806562
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosis.
Zhang JY
Cancer Detect Prev; 2004; 28(2):114-8. PubMed ID: 15068835
[TBL] [Abstract][Full Text] [Related]
7. Protein arrays as tools for serum autoantibody marker discovery in cancer.
Kijanka G; Murphy D
J Proteomics; 2009 Aug; 72(6):936-44. PubMed ID: 19258055
[TBL] [Abstract][Full Text] [Related]
8. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
9. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer.
Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J
Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Associated Antigens (TAAs) for the Serological Diagnosis of Osteosarcoma.
Li J; Qin B; Huang M; Ma Y; Li D; Li W; Guo Z
Front Immunol; 2021; 12():665106. PubMed ID: 33995397
[TBL] [Abstract][Full Text] [Related]
11. Immunotheranostics: breaking tolerance in immunotherapy using tumor autoantigens identified on protein microarrays.
Chatterjee M; Draghici S; Tainsky MA
Curr Opin Drug Discov Devel; 2006 May; 9(3):380-5. PubMed ID: 16729735
[TBL] [Abstract][Full Text] [Related]
12. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.
Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J
Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated autoantibodies as diagnostic and prognostic biomarkers.
Heo CK; Bahk YY; Cho EW
BMB Rep; 2012 Dec; 45(12):677-85. PubMed ID: 23261052
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer.
Wang P; Song C; Xie W; Ye H; Wang K; Dai L; Zhang Y; Zhang J
J Immunol Res; 2014; 2014():512540. PubMed ID: 24822225
[TBL] [Abstract][Full Text] [Related]
16. Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis.
Shi JX; Qin JJ; Ye H; Wang P; Wang KJ; Zhang JY
Expert Rev Mol Diagn; 2015 Jun; 15(6):829-52. PubMed ID: 25959246
[TBL] [Abstract][Full Text] [Related]
17. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY
Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors.
Zhang JY; Tan EM
Expert Rev Mol Diagn; 2010 Apr; 10(3):321-8. PubMed ID: 20370589
[TBL] [Abstract][Full Text] [Related]
19. Development of autoantibody signatures for common cancers.
Kobayashi M; Katayama H; Fahrmann JF; Hanash SM
Semin Immunol; 2020 Feb; 47():101388. PubMed ID: 31924500
[TBL] [Abstract][Full Text] [Related]
20. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
